Achievements and Prospects for Vascular Surgery in Treatment of Vertebrobasilar Insufficiency
- 作者: Kondaraki A.V.1, Chupin A.V.1,2, Alekyan B.G.1,2, Kul'bak V.A.1,3
-
隶属关系:
- A. V. Vishnevsky National Medical Research Center of Surgery
- Russian Medical Academy of Continuous Professional Education
- Lomonosov Moscow State University
- 期: 卷 30, 编号 4 (2022)
- 页面: 563-574
- 栏目: Reviews
- URL: https://journals.rcsi.science/pavlovj/article/view/252595
- DOI: https://doi.org/10.17816/PAVLOVJ109601
- ID: 252595
如何引用文章
详细
Vertebrobasilar insufficiency (VBI) remains an important problem in the modern medicine since approximately every fourth cerebral infarction occurs in the posterior circulation of the brain. These strokes are accompanied by severe consequences and a high risk of repeated events. The article presents the current concepts for surgical treatment of lesions of the subclavian (ScA) and vertebral (VA) arteries responsible for the development of VBI. In the open surgical treatment of symptomatic lesion of the ScA, primarily of occlusion one, extrathoracic interventions prevail in the form of carotid-subclavian bypass and carotid-subclavian transposition. According to our analysis, the results of carotid-subclavian transposition prove to be more preferable. In the endovascular intervention on the ScA, balloon angioplasty is used with possible stenting. In the analysis, we found no differences in the long-term patency between angioplasty and stenting, although the extent of technical success was higher in the group of stenting. In case of stenosis of the ScA, the world medicine gives priority to endovascular methods. To date, there are no sharply defined criteria permitting to choose between the open and endovascular interventions for treatment of the ScA occlusion, although a probable technical failure of endovascular revascularization and higher long-term patency give priority to open surgery. As for symptomatic stenosis of VA, to date there is no evidence of the advantage of stenting over conservative therapy. Thus, surgical intervention should rather be used in case the drug treatment is ineffective. The same can be said about the open reconstruction of the VA, except for the cases of contraindications for stenting of the VA, for example, its tortuosity.
作者简介
Artur Kondaraki
A. V. Vishnevsky National Medical Research Center of Surgery
Email: kondarakiarthur@gmail.com
ORCID iD: 0000-0002-8009-4769
SPIN 代码: 5434-7393
Researcher ID: ABD-3343-2021
俄罗斯联邦, Moscow
Andrey Chupin
A. V. Vishnevsky National Medical Research Center of Surgery; Russian Medical Academy of Continuous Professional Education
Email: achupin@rambler.ru
ORCID iD: 0000-0002-5216-9970
SPIN 代码: 7237-4582
Scopus 作者 ID: 6603104796
Researcher ID: ABD-5195-2021
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Moscow; MoscowBagrat Alekyan
A. V. Vishnevsky National Medical Research Center of Surgery; Russian Medical Academy of Continuous Professional Education
编辑信件的主要联系方式.
Email: bagratalekyan@gmail.com
ORCID iD: 0000-0001-6509-566X
SPIN 代码: 1544-2818
Scopus 作者 ID: 6603583917
Researcher ID: F-2662-2014
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Moscow; MoscowVladimir Kul'bak
A. V. Vishnevsky National Medical Research Center of Surgery; Lomonosov Moscow State University
Email: v_kulbak@mail.ru
ORCID iD: 0000-0001-6743-4012
SPIN 代码: 1111-0538
Scopus 作者 ID: 36650978100
Researcher ID: ABD-3334-2021
MD, Cand. Sci. (Med.);
俄罗斯联邦, Moscow; Moscow参考
- Rockman CB, Maldonado TS. Cerebrovascular Disease Epidemiology and Natural History. In: Sidawy AN, Perler BA, editors. Rutherford’s Vascular Surgery and Endovascular Therapy. 9th ed. Philadelphia: Elsevier; 2019. Vol. 2. P. 3766–826.
- Feigin VL, Stark BA, Johnson CO, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. Neurology. 2021;20(10):795–820. doi: 10.1016/S1474-4422(21)00252-0
- Bogousslavsky J, van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke. 1988;19(9):1083–92. doi: 10.1161/01.STR.19.9.1083
- Michel P, Odier C, Rutgers M, et al. The Acute STroke Registry and Analysis of Lausanne (ASTRAL). Stroke. 2010;41(11):2491–8. doi: 10.1161/STROKEAHA.110.596189
- Markus HS, van der Worp HB, Rothwell PM. Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary prevention. The Lancet. Neurology. 2013;12(10):989–98. doi: 10.1016/S1474-4422(13)70211-4
- Pallesen L–P, Lambrou D, Eskandari A, et al. Perfusion computed tomography in posterior circulation stroke: predictors and prognostic implications of focal hypoperfusion. European Journal of Neurology. 2018;25(5):725–31. doi: 10.1111/ene.13578
- Naylor AR, Ricco J–B, de Borst GJ, et al. Editor’s Choice — Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). European Journal of Vascular and Endovascular Surgery. 2018;55(1):3–81. doi: 10.1016/j.ejvs.2017.06.021
- Coward LJ, McCabe DJH, Ederle J, et al. Long-Term Outcome After Angioplasty and Stenting for Symptomatic Vertebral Artery Stenosis Compared With Medical Treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS). Stroke. 2007;38(5):1526–30. doi: 10.1161/STROKEAHA.106.471862
- Markus HS, Larsson SC, Kuker W, et al. Stenting for symptomatic vertebral artery stenosis: The Vertebral Artery Ischaemia Stenting Trial. Neurology. 2017;89(12):1229–36. doi: 10.1212/WNL.0000000000004385
- Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014;383(9914):333–41. doi: 10.1016/S0140-6736(13)62038-3
- Compter A, van der Worp HB, Schonewille WJ, et al. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial. The Lancet. Neurology. 2015;14(6):606–14. doi: 10.1016/S1474-4422(15)00017-4
- Benhammamia M, Mazzaccaro D, Mrad MB, et al. Endovascular and Surgical Management of Subclavian Artery Occlusive Disease: Early and Long-Term Outcomes. Annals of Vascular Surgery. 2020;66:462–9. doi: 10.1016/j.avsg.2019.11.041
- Galyfos GC, Kakisis I, Maltezos C, et al. Open versus endovascular treatment of subclavian artery atherosclerotic disease. Journal of Vascular Surgery. 2019;69(1):269–79.e7. doi: 10.1016/J.JVS.2018.07.028
- Aboyans V, Ricco J–B, Bartelink M–LEL, et al. ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European Heart Journal. 2018;39(9):763–816. doi: 10.1093/eurheartj/ehx095
- Natsional’nyye rekomendatsii po vedeniyu patsiyentov s zabolevaniyami brakhiotsefal’nykh arteriy. Angiology and Vascular Surgery. 2013;19(S2):4–68. (In Russ).
- Naylor AR, Rantner B, Ancetti S, et al. European society for vascular surgery (ESVS) 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease. European Journal of Vascular and Endovascular Surgery. 2022;S1078-5884(22)00237-4. doi: 10.1016/J.EJVS.2022.04.011
- Berger L, Bouziane Z, Felisaz A, et al. Long-term results of 81 prevertebral subclavian artery angioplasties: a 26-year experience. Annals of Vascular Surgery. 2011;25(8):1043–9. doi: 10.1016/J.AVSG.2011.03.017
- Kikuchi T, Ishii A, Nakahara I, et al. Japanese Registry of Neuroendovascular Therapy: Extracranial Steno-occlusive Diseases Except for Internal Carotid Artery Stenosis. Neurologia Medico-Chirurgica. 2014;54(1):40–5. doi: 10.2176/NMC.ST2013-0194
- Schillinger M, Haumer M, Schillinger S, et al. Outcome of Conservative versus Interventional Treatment of Subclavian Artery Stenosis. Journal of Endovascular Therapy. 2002;9(2):139–46. doi: 10.1177/152660280200900201
- Epperla N, Ye F, Idris A, et al. Treatment-Related Cardiovascular Outcomes in Patients with Symptomatic Subclavian Artery Stenosis. Cureus. 2017;9(5):e1262. doi: 10.7759/cureus.1262
- Duran M, Grotemeyer D, Danch MA, et al. Subclavian carotid transposition: immediate and long-term outcomes of 126 surgical reconstructions. Annals of Vascular Surgery. 2015;29(3):397–403. doi: 10.1016/j.avsg.2014.09.030
- Cinar B, Enc Y, Kosem M, et al. Carotid-subclavian bypass in occlusive disease of subclavian artery: more important today than before. The Tohoku Journal of Experimental Medicine. 2004;204(1):53–62. doi: 10.1620/tjem.204.53
- Tendera M, Aboyans V, Bartelink M–L, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). European Heart Journal. 2011;32(22):2851–906. doi: 10.1093/eurheartj/ehr211
- Cinà CS, Safar HA, Laganà A, et al. Subclavian carotid transposition and bypass grafting: Consecutive cohort study and systematic review. Journal of Vascular Surgery. 2002;35(3):422–9. doi: 10.1067/mva.2002.120035
- Madenci AL, Ozaki CK, Belkin M, et al. Carotid-subclavian bypass and subclavian-carotid transposition in the thoracic endovascular aortic repair era. Journal of Vascular Surgery. 2013;57(5):1275–82.e2. doi: 10.1016/J.JVS.2012.11.044
- Kazantsev AN, Chernykh KP, Zarkua NE, et al. Optimal revascularization procedure for steel syndrome. Kardiologiya i Serdechno-sosudistaya Khirurgiya. 2021;14(2):195–201. (In Russ). doi: 10.17116/kardio202114021195
- Pokrovskiy AV, Golovyuk AL. Sostoyaniye sosudistoy khirurgii v Rossiyskoy Federatsii v 2018 godu. Angiology and Vascular Surgery. 2019;25(S2). (In Russ).
- Linni K, Ugurluoglu A, Mader N, et al. Endovascular Management versus Surgery for Proximal Subclavian Artery Lesions. Annals of Vascular Surgery. 2008;22(6):769–75. doi: 10.1016/j.avsg.2008.08.001
- Chatterjee S, Nerella N, Chakravarty S, et al. Angioplasty Alone Versus Angioplasty and Stenting for Subclavian Artery Stenosis — A Systematic Review and Meta-analysis. American Journal of Therapeutics. 2013;20(5):520–3. doi: 10.1097/MJT.0b013e31822831d8
- Ahmed AT, Mohammed K, Chehab M, et al. Comparing Percutaneous Transluminal Angioplasty and Stent Placement for Treatment of Subclavian Arterial Occlusive Disease: A Systematic Review and Meta-Analysis. Cardiovascular and Interventional Radiology. 2016;39(5):652–67. doi: 10.1007/s00270-015-1250-9
- Iared W, Mourão JE, Puchnick A, et al. Angioplasty versus stenting for subclavian artery stenosis. The Cochrane Database of Systematic Reviews. 2022;2(2):CD008461. doi: 10.1002/14651858.CD008461.pub4
- Dabus G, Moran CJ, Derdeyn CP, et al. Endovascular treatment of vertebral artery-origin and innominate/subclavian disease: indications and technique. Neuroimaging Clinics of North America. 2007;17(3):381–92. doi: 10.1016/j.nic.2007.03.005
- Onishi H, Naganuma T, Hozawa K, et al. Periprocedural and Long-Term Outcomes of Stent Implantation for De Novo Subclavian Artery Disease. Vascular and Endovascular Surgery. 2019;53(4):294–91. doi: 10.1177/1538574418824444
- Brountzos EN, Petersen B, Binkert C, et al. Primary stenting of subclavian and innominate artery occlusive disease: a single center’s experience. Cardiovascular and Interventional Radiology. 2004;27(6):616–23. doi: 10.1007/s00270-004-0218-y
- Soga Y, Tomoi Y, Fujihara M, et al. Perioperative and Long-term Outcomes of Endovascular Treatment for Subclavian Artery Disease from a Large Multicenter Registry. Journal of Endovascular Therapy. 2015;22(4):626–33. doi: 10.1177/1526602815590579
- AbuRahma AF, Bates MC, Stone PA, et al. Angioplasty and stenting versus carotid-subclavian bypass for the treatment of isolated subclavian artery disease. Journal of Endovascular Therapy. 2007;14(5):698–704. doi: 10.1177/152660280701400515
- Byrne C, Tawfick W, Hynes N, et al. Ten-year experience in subclavian revascularisation. A parallel comparative observational study. Vascular. 2016;24(4):378–82. doi: 10.1177/1708538115599699
- Niu G, Yan Z, Zhang B, et al. Endovascular Treatment of Chronic Total Occlusion in the Subclavian Artery: A Review of 23 Cases. Frontiers in Neurology. 2020;11:264. doi: 10.3389/fneur.2020.00264
- Cakar MA, Tatli E, Tokatli A, et al. Percutaneous endovascular therapy for symptomatic chronic total occlusion of the left subclavian artery. Singapore Medical Journal. 2018;59(10):534–8. doi: 10.11622/smedj.2018023
- Compter A, van der Worp HB, Algra A, et al. Prevalence and prognosis of asymptomatic vertebral artery origin stenosis in patients with clinically manifest arterial disease. Stroke. 2011;42(10):2795–800. doi: 10.1161/STROKEAHA.110.612903
- Markus HS, Harshfield EL, Compter A, et al. Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis. The Lancet. Neurology. 2019;18(7):666–73. doi: 10.1016/S1474-4422(19)30149-8
- Tank VH, Ghosh R, Gupta V, et al. Drug eluting stents versus bare metal stents for the treatment of extracranial vertebral artery disease: a meta-analysis. Journal of NeuroInterventional Surgery. 2016;8(8):770–4. doi: 10.1136/neurintsurg-2015-011697
- Vachev AN, Dmitriev OV, Stepanov MYu. Comparative analysis of results of revascularization of the first segment of vertebral arteries. Angiology and Vascular Surgery. 2019;25(2):103–8. (In Russ).
补充文件
